COVATEST
DEAD

Serial Number

90523824

Owner

Schaefflertanz Corporation

Attorney

Philip A Kantor

Filing Date

Feb 10, 2021

Add to watchlist:

No watchlists yet
View on USPTO

COVATEST Trademark

Serial Number: 90523824

COVATEST is a trademark filed by Schaefflertanz Corporation on February 10, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Schaefflertanz Corporation (5 trademarks)

3012 S Durango Dr
Las Vegas, NV 89117

Entity Type: 03

Trademark Details

Filing Date

February 10, 2021

Registration Date

Not Registered

Published for Opposition

October 26, 2021

Goods & Services

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious disease; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of infectious diseases; all of the foregoing relating to infectious disease, including COVID -19

Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of infectious disease; all of the foregoing relating to infectious disease, including COVID -19

Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing for viruses; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing of nucleic acids; all of the foregoing relating to infectious disease, including COVID -19

Research and development and consultation related thereto in the field of infectious disease testing; Research and development in the field of infectious disease testing; Research and development of technology in the field of infectious disease testing; Research and development services in the field of antibodies; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific research and development; all of the foregoing relating to infectious disease, including COVID -19

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 25, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 25, 2022 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 21, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 26, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 26, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 6, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 10, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 10, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 10, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 10, 2021 CNEA
ASSIGNED TO EXAMINER
Sep 7, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2021 NWOS
NEW APPLICATION ENTERED
Feb 15, 2021 NWAP